(2α,6α,11R*)-3-benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol (57573-46-3)

Identification
Name:	(2α,6α,11R*)-3-benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol
Synonyms:	(2alpha,6alpha,11R*)-3-Benzyl-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol;(2S,6S)-3-benzyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol
CAS:	57573-46-3
EINECS:	260-817-5
Molecular Formula:	C₂₁H₂₅NO
Molecular Weight:	307.4293
InChI:	InChI=1/C21H25NO/c1-15-20-12-17-8-9-18(23)13-19(17)21(15,2)10-11-22(20)14-16-6-4-3-5-7-16/h3-9,13,15,20,23H,10-12,14H2,1-2H3/t15?,20-,21-/m0/s1
Molecular Structure:
Properties
Flash Point:	211°C
Boiling Point:	442.1°C at 760 mmHg
Density:	1.125g/cm³
Refractive index:	1.606
Flash Point:	211°C
Safety Data

Other Product

(2α,6α,11R*)-()-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol
(2α,6α,11R*)-()-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-11-methyl-6-phenyl-3-(2-propen-1-yl)-, (2S,6S,11R)-
2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(2-(1,3-dioxan-2-yl)ethyl-, (2-alpha,6-alpha,11R*)-, (Z)-2-butenedioate (1:1) (salt)
2,6-Methano-3-benzazocin-8-ol,6-ethyl-1,2,3,4,5,6-hexahydro-3,11-dimethyl-, (2R,6R,11R)-rel-
6-ethyl-11-methyl-3-(prop-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-3,11-dimethyl-6-phenyl-, hydrochloride (1:1),(2S,6S,11R)-
2,6-Methano-3-benzazocin-8-ol,6-ethyl-1,2,3,4,5,6-hexahydro-3-(2-phenylethyl)-, hydrochloride (1:1)
2,6-Methano-3-benzazocin-8-ol,3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-11-methoxy-6-methyl-, (2R,6S,11R)-
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6- hexahydro-11-methyl-3-(3-methyl-2- butenyl)-6-phenyl-,(2R,6S,11S)-
2-hydroxypropanoic acid - 3-(cyclobutylmethyl)-6-ethyl-11,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol (1:1)
3-(3,3-Dichloro-2-propenyl)-6-ethyl-1,2,3,4,5,6-hexahydro-11-methyl-2,6-methano-3-benzazocin-8-ol
2,6-Methano-3-benzazocin-11-ol,1,2,3,4,5,6-hexahydro-8-methoxy-6-methyl-3-(2-phenylethyl)-, hydrobromide, (2a,6a,11S*)- (9CI)
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6- hexahydro-11-methyl-6-phenyl-3-(2- propynyl)-,methanesulfonate (salt)
(2α,3aβ,5α,6β,6aβ)]-hexahydro-4-methyl-2,5-methano-2H-furo[3,2-b]pyrrol-6-ol hydrobromide
Metaphosphoric acid (HPO3), compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (4:3), monosodium salt
6-methyl-3-(2-phenylethyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol hydrobromide
2,6-Methano-3-benzazocin-8-ol,6-ethyl-1,2,3,4,5,6-hexahydro-3-(2-phenylethyl)-
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-6-methyl-3-(2-phenylethyl)-
(1α,2β,4β,6α)-()-2,2,7-trimethyl-3-oxatricyclo[4.1.1.02,4]octane